Literature DB >> 9308599

Epidemiology and prevention of hypertension.

J He1, P K Whelton.   

Abstract

At least 43 million (24%) adults in the general population of the United States have hypertension. The prevalence of hypertension increases with age and is higher among African-Americans compared to other ethnic groups. During the past several decades, the prevalence of hypertension in the general population of the United States has declined and the proportion of hypertensives who are aware of their high blood pressure, as well as the portion who are being treated and controlled has improved. Hypertension is the most important modifiable risk factor for coronary heart disease, stroke, congestive heart failure, and end-stage renal disease. To achieve the final goal of eliminating all blood pressure-related disease in the community, detection and treatment of hypertension must be complemented by equally energetic approaches directed at primary prevention of hypertension. A small downward shift in the entire distribution of blood pressure in the general population will not only reduce the incidence of hypertension, but substantially diminish the burden of blood pressure in the general population.

Entities:  

Mesh:

Year:  1997        PMID: 9308599     DOI: 10.1016/s0025-7125(05)70568-x

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN: 0025-7125            Impact factor:   5.456


  37 in total

Review 1.  Cost per millimeter of mercury lowering is a measure of economic value for antihypertensive agents.

Authors:  R S Chen; P Lapuerta
Journal:  Curr Hypertens Rep       Date:  2000-12       Impact factor: 5.369

2.  Higher circulatory level of endothelin-1 in hypertensive subjects screened through a cross-sectional study of rural Bangladeshi women.

Authors:  Shamima Akter; Subrina Jesmin; Yoshio Iwashima; Sakuramoto Hideaki; Md Arifur Rahman; Md Majedul Islam; Masao Moroi; Nobutake Shimojo; Naoto Yamaguchi; Takashi Miyauchi; Satoru Kawano; Taro Mizutani; Yuhei Kawano
Journal:  Hypertens Res       Date:  2014-11-13       Impact factor: 3.872

3.  Association between the G-protein β3 subunit C825T polymorphism with essential hypertension: a meta-analysis in Han Chinese population.

Authors:  Jiapeng Lu; Qingqing Guo; Ling Zhang; Wei Wang
Journal:  Mol Biol Rep       Date:  2012-06-20       Impact factor: 2.316

4.  Coffee and caffeine consumption and the risk of hypertension in postmenopausal women.

Authors:  Jinnie J Rhee; FeiFei Qin; Haley K Hedlin; Tara I Chang; Chloe E Bird; Oleg Zaslavsky; JoAnn E Manson; Marcia L Stefanick; Wolfgang C Winkelmayer
Journal:  Am J Clin Nutr       Date:  2015-12-09       Impact factor: 7.045

5.  Antihypertensive effects of dietary protein and its mechanism.

Authors:  Sudesh Vasdev; Jennifer Stuckless
Journal:  Int J Angiol       Date:  2010

6.  Hypertension in older adults and the role of positive emotions.

Authors:  Glenn V Ostir; Ivonne M Berges; Kyriakos S Markides; Kenneth J Ottenbacher
Journal:  Psychosom Med       Date:  2006 Sep-Oct       Impact factor: 4.312

Review 7.  Prehypertension: Underlying pathology and therapeutic options.

Authors:  Sulayma Albarwani; Sultan Al-Siyabi; Musbah O Tanira
Journal:  World J Cardiol       Date:  2014-08-26

8.  Psychometric properties of the VSQLQ in black patients with mild hypertension. Vital Signs Quality of Life Questionnaire.

Authors:  N K Leidy; J K Schmier; A E Bonomi; M Legro; T Zyczynski; B W Kong
Journal:  J Natl Med Assoc       Date:  2000-12       Impact factor: 1.798

9.  Combined effects of hypertension and heart rate on the risk of stroke and coronary heart disease: a population-based prospective cohort study among Inner Mongolians in China.

Authors:  Chongke Zhong; Xiaoyan Zhong; Tian Xu; Hao Peng; Hongmei Li; Mingzhi Zhang; Aili Wang; Tan Xu; Yingxian Sun; Yonghong Zhang
Journal:  Hypertens Res       Date:  2015-08-20       Impact factor: 3.872

10.  Role of the immune system in hypertension: modulation by dietary antioxidants.

Authors:  Sudesh Vasdev; Jennifer Stuckless; Vernon Richardson
Journal:  Int J Angiol       Date:  2011-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.